BioNTech, Moderna and Johnson & Johnson are working on vaccines that specifically target Omicron in case their existing shots are not effective against the new coronavirus variant, the companies said on Monday, November 29. BioNTech SE said it had started work on a vaccine tailored to Omicron, along with partner Pfizer. Moderna Inc said it […]

Read more of this post


This free site is ad-supported. Learn more